D.E. Shaw & Co’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-71,264
| Closed | -$217K | – | 3408 |
|
|
2024
Q1 | $217K | Sell |
71,264
-7,003
| -9% | -$21.4K | ﹤0.01% | 2729 |
|
|
2023
Q4 | $252K | Sell |
78,267
-6,041
| -7% | -$19.5K | ﹤0.01% | 2616 |
|
|
2023
Q3 | $324K | Sell |
84,308
-22,974
| -21% | -$88.2K | ﹤0.01% | 2449 |
|
|
2023
Q2 | $352K | Sell |
107,282
-231,878
| -68% | -$761K | ﹤0.01% | 2449 |
|
|
2023
Q1 | $875K | Sell |
339,160
-167,167
| -33% | -$431K | ﹤0.01% | 2270 |
|
|
2022
Q4 | $942K | Sell |
506,327
-184,996
| -27% | -$344K | ﹤0.01% | 2457 |
|
|
2022
Q3 | $1.27M | Sell |
691,323
-198,041
| -22% | -$364K | ﹤0.01% | 2417 |
|
|
2022
Q2 | $1.91M | Buy |
889,364
+663
| +0.1% | +$1.43K | ﹤0.01% | 2290 |
|
|
2022
Q1 | $2.79M | Buy |
888,701
+129,605
| +17% | +$407K | ﹤0.01% | 2189 |
|
|
2021
Q4 | $2.44M | Buy |
759,096
+30,166
| +4% | +$96.8K | ﹤0.01% | 2259 |
|
|
2021
Q3 | $2.45M | Sell |
728,930
-16,985
| -2% | -$57.1K | ﹤0.01% | 1969 |
|
|
2021
Q2 | $2.92M | Buy |
745,915
+160,210
| +27% | +$627K | ﹤0.01% | 1802 |
|
|
2021
Q1 | $2.36M | Buy |
585,705
+373,312
| +176% | +$1.5M | ﹤0.01% | 1773 |
|
|
2020
Q4 | $490K | Buy |
+212,393
| New | +$490K | ﹤0.01% | 2295 |
|